Skip to main content
Jamie E. Flerlage, MD, MS
Jamie E. Flerlage, MD, MS

Jamie E. Flerlage, MD, MS

Assistant Member, St. Jude Faculty




BS – Union College, Albany New York
MD – Albany Medical College, Albany, New York
MS – Union Graduate College, Schenectady, New York
Internship/Residency (Pediatrics) – Johns Hopkins Hospital, Baltimore, Maryland
Fellowship (Pediatric Hematology/Oncology) – St. Jude Children’s Research Hospital

Honors & Awards

  • 2016  St. Jude Children’s Research Hospital Teaching Award

Research Interests

  • Protocol development and clinical investigations in Hodgkin Lymphoma
  • Genetic causes of childhood cancer
  • International collaboration and protocol development

Clinical Interests

  • Hodgkin lymphoma

Selected Publications

Flerlage JE, von Buttlar X, Krasin M, Triplett B, Kaste SC, Metzger ML. Brentuximab Vedotin as Consolidation after Hematopoetic Cell Transplant for Relapsed Hodgkin Lymphoma in Pediatric Patients. Pediar Blood Cancer Aug 20, 2019 (Epub ahead of print). PMID: 31429511

Flerlage JE, Metzger ML, Bhakta N. The management of Hodgkin lymphoma in adolescents and young adults: burden of disease or burden of choice? Blood 132(4):376-384, 2018. PubMed PMID: 29895665 PMCID: PMC6071556

Flerlage, JE, Kelly K, Beishuizen A, et al. Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology Statement. Pediatr Blood Cancer 64(7), 2017. PubMed PMID: 28097818

Flerlage JE, Metzger M, Wu J, Panetta C. Pharmacokinetics, Immunogenicity, and Safety of Weekly Dosing of Brentuximab in Pediatric Patients with Hodgkin Lymphoma. Cancer Chemother Pharmacol 78: pages 1217-1223, 2016. PubMed PMID: 27837256 PMCID: PMC5206991 

Engorn BM, Flerlage JE. The Harriet Lane Handbook. 20th ed. Philadelphia, PA: Elsevier; 2014.

Last update: September 2019